FDA — authorised 29 October 1980
- Application: NDA018202
- Marketing authorisation holder: NOVARTIS
- Local brand name: CYTADREN
- Indication: TABLET — ORAL
- Status: approved
🇺🇸 Cytadren in United States
FDA authorised Cytadren on 29 October 1980
Marketing authorisations
FDA
- Status: approved
Cytadren in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Oncology approved in United States
Frequently asked questions
Is Cytadren approved in United States?
Yes. FDA authorised it on 29 October 1980; FDA has authorised it.
Who is the marketing authorisation holder for Cytadren in United States?
NOVARTIS holds the US marketing authorisation.